Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • FAQs
    • Enterprise Admin Support
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Just Launched! RxAdvanced hospital competency training for pharmacists and PTU Elite: Immunizations pharmacy technician training program. Get a quote.

  1. Home
  2. Browse
  3. Renal & Urology
  4. UTIs

UTIs

  • Benign Prostatic Hypertrophy (6)
  • Cystitis (1)
  • Drug-Induced Nephrotoxicity (63)
  • Drug Use in Renal Insufficiency (150)
  • Hyperkalemia (8)
  • Incontinence (2)
  • Kidney Disease (16)
  • Kidney Stones (13)
  • Nephrology (27)
  • Overactive Bladder (10)
  • Resources (47)
  • Urinary Retention (2)
  • UTIs (50)
  • Urine Drug Testing (8)
31 - 45 of 50 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Verify Catheters are Removed in Your Post­Operative Patients January 2016
PL Voices: Appropriate Medication Use in Older Adults: 2015 Updated Beers Criteria December 2015
Article: Use Beers Criteria to Update Your High-Risk Readmission Screening Tool December 2015
PL Voices: Cardiovascular Outcomes with Empagliflozin (Jardiance) November 2015
Commentary: Empagliflozin and Cardiovascular Disease November 2015
Article: Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon November 2015
Commentary: New Drug: Avycaz (Ceftazidime/Avibactam) May 2015
Article: Reduce Ceftazidime/Avibactam Doses in Renal Insufficiency May 2015
Commentary: Asymptomatic Bacteriuria FAQs April 2015
Article: Don't Start Antibiotics Just For Cloudy Urine April 2015
Commentary: New Drug: Zerbaxa (Ceftolozane/Tazobactam) March 2015
Article: Watch for Dosing Confusion with Ceftolozane/Tazobactam March 2015
Commentary: Antimicrobial Stewardship November 2014
PL Voices: Role of SGLT2 Inhibitors for Type 2 Diabetes October 2014
PL Voices: Safety of Quinolone Antibiotics in Children August 2014
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved